The Speedboat RS2 device, developed by Creo Medical Ltd, is an advanced bipolar electrosurgical tool designed for minimally invasive endoscopic procedures like Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM). It features a 4.
The Speedboat RS2 device, developed by Creo Medical Ltd, is an advanced bipolar electrosurgical tool designed for minimally invasive endoscopic procedures like Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM). It features a 4.2-mm distal cutting section, proximal insulated areas, an integrated injection needle, and utilizes bipolar radiofrequency for cutting and microwave energy for coagulation. These features ensure precise tissue dissection, effective hemostasis, and minimal thermal damage.
The device is ideal for en bloc resection of gastrointestinal lesions, submucosal tumor excision, and treating esophageal motility disorders. Its integrated cutting, coagulation, and injection functionalities streamline workflows, reduce procedural time, and enhance safety. Clinical studies demonstrate its efficacy in reducing bleeding risks, lowering adverse events, and improving recovery outcomes compared to traditional monopolar tools. The Speedboat RS2 is versatile, user-friendly, and particularly effective for lesions in anatomically challenging locations.
Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...
Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...
Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...
Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...
Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...
Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.